View the article online at http://citywire.co.uk/money/article/a1001435
Overnight Markets: Healthcare stocks weigh on Wall Street
Biogen weighed down the S&P 500, falling 4.7% after two brokerages downgraded the stock.
Markets

The Dow Jones and S&P 500 slip on Thursday, weighed down by declines in shares of healthcare and energy companies amid concerns about inaction on key legislative priorities in Washington.
The Dow Jones Industrial Average fell 16 points, or 0.07%, to close at 20,935, the S&P 500 lost four points, or 0.16%, to 2,381 and the Nasdaq Composite added one point, or 0.01%, to 5,901.
The S&P 500 healthcare index fell 0.9% after proposals in President Donald Trump's budget signalled higher regulatory costs for the healthcare sector and a cut in federal funding for medical research.
Financials outperformed in a rebound after the sector was the worst performer on Wednesday and as the benchmark US Treasury note yield rose, while utilities weakened.
Biogen (BIIB.O) weighed down the S&P 500, falling 4.7% after two brokerages downgraded the stock.
Technology stocks did better, led by Oracle (ORCL.N), which surged 6.2%, after it posted a better-than-expected quarterly profit.
GoPro, which makes wearable cameras, surged 15.8% after it announced a cost-cutting plan and said it's sticking by its forecast for 2017 profit.
Tesla Motors climbed 2.5% as it announced plans to raise $1 billion in new offerings of stock and bonds to strengthen the company's balance sheet.
Williams-Sonoma climbed 2.4% as it boosted its quarterly dividend by five percent after fourth-quarter earnings rose 2.5% to $144.6 million.
Tyson Foods (TSN.N) slipped 1.7% on news that a form of bird flu that is highly lethal for poultry had infected a second farm that supplies Tyson.
Trovagene plunged 25.7% after the San Diego developer of diagnostic technology posted disappointing financial results.
In Asia, equities traded mixed on Friday in morning session following a flat to lower close on Wall Street, in a light regional data day.
Japanese benchmark Nikkei 225 fell 0.35%. Australia's ASX 200 added 0.39%, buoyed by its gold sub-index, which was up 1.61%. In South Korea, the Kospi was up 0.27%. China's Shanghai composite was almost flat in early trade and the Shenzhen composite gained 0.2%. Hong Kong's Hang Seng added 0.35%.
News sponsored by:
The Citywire Guide to Investment Trusts
In this guide to investment trusts, produced in association with Aberdeen Asset Management, we spoke to many of the leading experts in the field to find out more.
Today's articles





Tools from Citywire Money
Weekly email from The Lolly
Get simple, easy ways to make more from your money. Just enter your email address below
An error occured while subscribing your email. Please try again later.
Thank you for registering for your weekly newsletter from The Lolly.
Keep an eye out for us in your inbox, and please add noreply@emails.citywire.co.uk to your safe senders list so we don't get junked.
Read more...
Nigel Thomas to retire after 40 years in funds
by Daniel Grote on Apr 26, 2018 at 16:42
1 comment so far. Why not have your say?
SDRL
Mar 17, 2017 at 16:56
UPDATE:
JNJ and GSK are now trading higher. I own both stocks are trading higher. I especially like GSK because it resembles JNJ with both drugs and great consumer products. Donald Trump has appointed to head the FDA a person who well be very fair to the pharmaceutical industry.
report thisleave a comment
Please sign in here or register here to comment. It is free to register and only takes a minute or two.